Related references
Note: Only part of the references are listed.Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients
Atsushi Ono et al.
JOURNAL OF HEPATOLOGY (2012)
Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs
W. Chotiyaputta et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Obstruction at Middle Hepatic Venous Tributaries in Modified Right Lobe Grafts after Living-Donor Liver Transplantation: Diagnosis with Contrast-enhanced US
Yang Shin Park et al.
RADIOLOGY (2012)
Three Years of Continuous Entecavir Therapy in Treatment-Naive Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety
Man-Fung Yuen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B
Kyung Ho Han et al.
ANTIVIRAL THERAPY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
Watcharasak Chotiyaputta et al.
JOURNAL OF HEPATOLOGY (2011)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone
Ju Hyun Shim et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2009)
Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides
M. H. Nguyen et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of hepatitis B e antigen - Positive chronic hepatitis with telbivudine or adefovir
Henry L. Y. Chan et al.
ANNALS OF INTERNAL MEDICINE (2007)
Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response
Man-Fung Yuen et al.
HEPATOLOGY (2007)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B
H. L. -Y. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B
HJ Yuan et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
MF Yuen et al.
HEPATOLOGY (2001)
Share Paper
